Corrigendum to: Reducing the Initial Number of Rituximab Maintenance-Therapy Infusions for ANCA-associated Vasculitides: Randomized-Trial Post-Hoc Analysis - Sorbonne Université Access content directly
Journal Articles Rheumatology Year : 2020

Corrigendum to: Reducing the Initial Number of Rituximab Maintenance-Therapy Infusions for ANCA-associated Vasculitides: Randomized-Trial Post-Hoc Analysis

Noémie Jourde-Chiche
  • Function : Author
Pierre Gobert
  • Function : Author
Jean-François Viallard
  • Function : Author
Jean Sibilia
  • Function : Author
Luc Mouthon

Dates and versions

hal-03894245 , version 1 (12-12-2022)

Identifiers

Cite

Pierre Charles, Agnès Dechartres, Benjamin Terrier, Pascal Cohen, Stanislas Faguer, et al.. Corrigendum to: Reducing the Initial Number of Rituximab Maintenance-Therapy Infusions for ANCA-associated Vasculitides: Randomized-Trial Post-Hoc Analysis. Rheumatology, 2020, 59 (10), pp.3119--3119. ⟨10.1093/rheumatology/keaa222⟩. ⟨hal-03894245⟩
16 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More